UPCOMING SUBMISSION DEADLINES
European Association for the Study of Obesity – Novo Nordisk Foundation Obesity Prize and Awards for Scientific Excellence Announced
Friday, 15th December 2023
The European Association for the Study of Obesity (EASO) and the Novo Nordisk Foundation have announced an Obesity Prize for Excellence. This new award recognizes outstanding research or technological contributions to the understanding of obesity, its aetiology, complications, prevention and treatment. The prize is supported by a grant of DKK 2,000,000; DKK 300,000 of which is a personal grant to the winner.
15th September is the application deadline for our 2023 ECN Winter School ‘Hot Topics in Obesity’ and 2023 Masterclass ‘A Multidisciplinary Approach to Obesity’ — both taking place:
30 November – 2 December in Antalya, Türkiye
2023 ECN Winter School ‘Hot Topics in Obesity’
This residential, educational course is open to early career researchers and practitioners who are members of the ECN. The Programme for 2023 will focus on ‘Hot Topics in Obesity’ with sessions addressing key issues in research, treatment and public health.
2023 Masterclass ‘A Multidisciplinary Approach to Obesity’
To address the wide disparities in obesity care and public health strategies,EASO education programmes offer comprehensive training designed for European health professionals working in obesity prevention and management.
Join the ECN network
ROYAL SOCIETY SPECIAL JOURNAL PUBLICATION ANNOUNCED
A special 2-part issue focused on obesity. The journal issue, from Philosophical Transactions B, is titled Causes of obesity: theories, conjectures and evidence which has been compiled and edited by John R Speakman, Thorkild IA Sørensen, Kevin D Hall and David B Allison.
Mastering Statistics in Obesity Research with Dr Paul Christiansen
In this 1-hour session, Dr. Christiansen will share practical tips for success with statistics and address common stumbling blocks faced by researchers when analysing data in the realm of obesity research.
19 September, 4-5pm BST
14-17 October, Dallas, Texas
Join colleagues from EASO and around the world for ObesityWeek® 2023 in Dallas, Texas, next month hosted by The Obesity Society.
The event features evidence-based obesity science, cutting-edge basic and clinical research, state-of-the-art obesity treatment and prevention, advocacy and public policy.
Early Career Programme – UK Congress on Obesity
13 September in Belfast, Ireland
ASCEND Obesity Training in Madrid from 18-22 September 2023.
18-22 September in Madrid, Spain
Austrian Obesity Society & The Austrian Society for Metabolic and Bariatric Surgery Annual Conference
12-13 October, Vienna, Austria
9th Central European Congress on Obesity
13-14th October in 30th August – 1st September in Prague, Czech Republic
Conference – Prevention of Childhood Obesity
30 October – 3 November in Copenhagen, Denmark
2024 Nordic Obesity Meeting will take place 1–3 February 2024 in Helsinki, Finland.
Abstract submission deadline: 14th September
1-3 February 2024 in Helsinki, Finland
16th European Public Health (EPH) Conference
8 – 11 November in Dublin, Ireland
14th European Nutrition Conference FENS 2023
14 – 17th November in Belgrade, Serbia
OBESITY FACTS JOURNAL
Read the latest edition of OBESITY FACTS, THE EUROPEAN JOURNAL OF OBESITY
Volume 16, Issue 4, and online first articles are all available open access
- The Physiology of Neurogenic Obesity: Lessons from Spinal Cord Injury Research
- Disease Burden and Health Status among People with Severe Obesity Who Do Not Receive Bariatric Surgery: A Retrospective Study
- Soluble (Pro)Renin Receptor Level in Patients with Severe Obesity is Associated with Visceral Adiposity and Is Involved with Insulin Resistance and Renal Injury
- Insulin Resistance, but Not Obstructive Sleep Apnea Is Associated with Hepatic Steatosis in Chinese Patients with Severe Obesity
- Association of Body Fat Distribution and risk of Breast cancer in Pre- and Postmenopausal Women
- The Impact of Obesity on T and NK Cells after LVAD Implantation
- Antibody Response to Inactive SARS-CoV-2 Vaccination in a Cohort of Elderly Patients Living with Obesity
- The Effect of a Multifaceted Intervention Including Classroom Education and Bariatric Weight Suit Use on Medical Students’ Attitudes toward Patients with Obesity
- Liver-Expressed Antimicrobial Peptide 2 Is a Hepatokine That Predicts Weight Loss and Complete Remission of Type 2 Diabetes Mellitus after Vertical Sleeve Gastrectomy in Japanese Individuals.
- Reduced Growth Hormone Predicts Worsening Adipose Tissue Insulin Resistance in Adults with Obesity
Save the Date
The 31st European Congress on Obesity (ECO 2024) will take place 12-15 May 2024 in Venice, Italy – save the dates!
We look forward to hosting you in Venice.
SWEET Consortium position: WHO guideline on non-sugar sweeteners
The World Health Organization (WHO) recently issued a “conditional recommendation” on non-sugar sweeteners (NSS), sparking discussions and concerns regarding their potential impact on human health.
This guideline is based on a comprehensive systematic review of Randomized Controlled Trials (RCTs) and particularly observational studies, which advise against using NNS for weight control.
Introducing Bio-Streams: Addressing Childhood and Adolescent Obesity in the EU
Bio-Streams, a new Horizon Europe Research and Innovation project designed to address the growing epidemic of underage obesity in the European Union, is excited to announce its official launch.
This groundbreaking project combines data-driven research, prevention measures and community participation to provide a holistic approach to reducing obesity rates among children and adolescents.
Proactive Strategies for Addressing Childhood Obesity and reducing Future Cancer Risks
EASO is delighted to partner with the European Health Management Association in a new project, PREVENT — improving and upscaling primary prevention of cancer by addressing childhood obesity through implementation research.
EASO is pleased to support this 5 year EU funded H2020 initiative. TIMESPAN, led by scientific coordinator Professor Henrik Larsson (Örebro University), includes 17 partners from across academia, industry, and patient advocacy communities, and aims to foster improvement in clinical management of adults living with with ADHD and co-occurring cardiometabolic disease, including obesity.